Cargando…

Comparison between clinical trials and real-world evidence studies on biologics for severe asthma

In recent years, the more widespread availability of biological drugs with specific mechanisms of action has led to significant breakthroughs in the management of severe asthma. Over time, numerous randomised clinical trials have been conducted to evaluate the efficacy and safety of these biologics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menzella, Francesco, Ballarin, Andrea, Sartor, Maria, Floriani, Ariel Fabian, Corsi, Lorenzo, Dartora, Cristina, Tonin, Silvia, Romagnoli, Micaela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703569/ https://www.ncbi.nlm.nih.gov/pubmed/36420737 http://dx.doi.org/10.1177/03000605221133689

Ejemplares similares

Real world effectiveness of benralizumab on respiratory function and asthma control
por: Menzella, Francesco, et al.
Publicado: (2021)

A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM)
por: Menzella, Francesco, et al.
Publicado: (2021)

Biologics in severe asthma: the role of real-world evidence from registries
por: Paoletti, Giovanni, et al.
Publicado: (2022)

Baseline Characteristics of Patients Enrolled in Clinical Trials of Biologics for Severe Asthma as Potential Predictors of Outcomes
por: Menzella, Francesco
Publicado: (2023)

Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series
por: Menzella, Francesco, et al.
Publicado: (2021)

Bronchial thermoplasty in severe asthma: a real-world study on efficacy and gene profiling
por: Facciolongo, Nicola, et al.
Publicado: (2022)

Roles of real-world evidence in severe asthma treatment: challenges and opportunities
por: Lee, Youngsoo, et al.
Publicado: (2023)

Oral Corticosteroids Dependence and Biologic Drugs in Severe Asthma: Myths or Facts? A Systematic Review of Real-World Evidence
por: Calzetta, Luigino, et al.
Publicado: (2021)

Real-world benefits of biologics for asthma: Exacerbation events and systemic corticosteroid use
por: Kimura, Yuya, et al.
Publicado: (2021)

Tailored therapy for severe asthma
por: Menzella, Francesco, et al.
Publicado: (2015)

Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis
por: Caruso, Cristiano, et al.
Publicado: (2022)

Development of a real-world database for asthma and COPD: The SingHealth-Duke-NUS-GSK COPD and Asthma Real-World Evidence (SDG-CARE) collaboration
por: Lam, Sean Shao Wei, et al.
Publicado: (2023)

Targeting eosinophils: severe asthma and beyond
por: Caminati, Marco, et al.
Publicado: (2019)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021)

Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab
por: Menzella, Francesco, et al.
Publicado: (2021)

Biologics for psoriasis patients under 18 years of age: Real-world evidence from the Chinese psoriasis real world evidence research group
por: Zheng, Yu-Xin, et al.
Publicado: (2022)

Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine
por: Scuteri, Damiana, et al.
Publicado: (2022)

The clinical profile of benralizumab in the management of severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Cell biology and the “real world”
por: Blackstone, Craig, et al.
Publicado: (2016)

A real-world implementation of asthma clinic: Make it easy for asthma with Easy Asthma Clinic
por: Boonsawat, Watchara, et al.
Publicado: (2022)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study
por: Menzies-Gow, Andrew N, et al.
Publicado: (2022)

Interstitial lung abnormalities: Real‐world evidence
por: Rôlo Silvestre, Carina, et al.
Publicado: (2023)

Effects of Asthma Medication Type on Asthma Exacerbation in a Real-World Setting
por: Choi, Yong Jun, et al.
Publicado: (2022)

Clinical asthma phenotypes in the real world: opportunities and challenges
por: Bostantzoglou, Clementine, et al.
Publicado: (2015)

Characterizing Real-World Use Of Tiotropium In Asthma In The USA
por: Averell, Carlyne M, et al.
Publicado: (2019)

Risk Factors Predicting Severe Asthma Exacerbations in Adult Asthmatics: A Real-World Clinical Evidence
por: Ban, Ga-Young, et al.
Publicado: (2021)

Increased Risk of Hypothyroidism in People with Asthma: Evidence from a Real-World Population-Based Study
por: Huang, Shih-Cheng, et al.
Publicado: (2022)

Real-World Evidence for Equality
por: Johnson, C. Erwin, et al.
Publicado: (2021)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Severe refractory asthma: current treatment options and ongoing research
por: Menzella, Francesco, et al.
Publicado: (2018)

The Korean Severe Asthma Registry (KoSAR): real world research in severe asthma
por: Kim, Sang-Heon, et al.
Publicado: (2022)

A Comparison of the Effectiveness of Asthma Medications on Asthma Exacerbations in Real World National Cohort
por: Park, Hye Jung, et al.
Publicado: (2022)

Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?
por: Menzella, Francesco, et al.
Publicado: (2017)

Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
por: Lin, Pei-Tzu, et al.
Publicado: (2018)

The Role of Real‐World Evidence in FDA‐Approved New Drug and Biologics License Applications
por: Purpura, Christina A., et al.
Publicado: (2021)

Efficacy of Allergen Immunotherapy for Allergic Asthma in Real World Practice
por: Rhyou, Hyo-In, et al.
Publicado: (2019)

Clinical Asthma Remission Obtained with Biologics in Real Life: Patients’ Prevalence and Characteristics
por: Sposato, Bruno, et al.
Publicado: (2023)

Informing real-world practice with real-world evidence: the value of PRECIS-2
por: Neta, Gila, et al.
Publicado: (2018)

Proceed with Caution When Using Real World Data and Real World Evidence
por: Kim, Hun-Sung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3qsd528k1ot6n23rrnejjek89m